Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CYDY - CytoDyn: Biopharma's Troublemaker Or Its Unappreciated Gem

CYDY - CytoDyn: Biopharma's Troublemaker Or Its Unappreciated Gem

CytoDyn Inc
  • CytoDyn has a single asset - leronlimab - which it is running through trials in nearly every major disease known to man.
  • The stock has seen huge movement after the company started with covid-19.
  • If the company manages to file its HIV BLA, the stock could shoot up.

For further details see:

CytoDyn: Biopharma's Troublemaker, Or Its Unappreciated Gem
Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...